Clinical Associations of Hypocholesterolaemia

  • B. Lewis
  • M. Mancini
Conference paper

Abstract

There is cogent evidence to justify the treatment of hypercholesterolaemia in individuals with elevated levels of low density lipoprotein (LDL), and to reduce the mean plasma cholesterol of populations at high risk of coronary disease (1,2). However cholesterol and its precursor hydroxymethylglutaryl CoA are important metabolic intermediates, and unesterified cholesterol is an obligatory component of the plasma membranes of all cells. As circulating LDL is a major source of the cholesterol of extrahepatic cells, it may be hypothesized that very low plasma levels of this lipoprotein may have untoward effects. The hypothesis merits critical examination, for it has bearing on recommendations to the population to restrict intake of saturated fatty acids and cholesterol, and on the use of lipid- lowering drugs in clinical practice.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Grundy SM (chairman). Rationale of the diet-heart statement of the American Heart Association. Report of Nutrition Committee. Circulation 1982, 65: 339A-854AGoogle Scholar
  2. 2.
    Lewis B. Ischaemic heart disease: the scientific bases of prevention. In Progress in Cardiology 10. Eds JF Goodwin, PN Yu, 1981. Philadelphia: Lea and FebigerGoogle Scholar
  3. 3.
    Feinleib M. Workshop on cholesterol and noncardiovascular mortality. Prev Med 1982, 11: 360–67PubMedCrossRefGoogle Scholar
  4. 4.
    Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries with special reference to dietary practices. Int J Cancer 1975, 15: 617–31PubMedCrossRefGoogle Scholar
  5. 5.
    Carroll KK. Lipids and carcinogenesis. J Env Path Toxicol 1980, 3: 253–71Google Scholar
  6. 6.
    Liu K, Stamler J, Moss D, Garside D, Persky V, Soltero I. Dietary cholesterol, fat, fibre and colon cancer mortality: an analysis of international data. Lancet 1979, ii: 782–35CrossRefGoogle Scholar
  7. 7.
    Reddy BS, Cohen LA, McCoy GD, Hill P, Weisburger JH, Wynder EL. Nutrition and its relationship to cancer. Adv Cancer Res 1980, 32: 237–343PubMedCrossRefGoogle Scholar
  8. 8.
    Doll R, Peto R. The causes of cancer. J Nat Cancer Inst 1981, 66: 1191–1308PubMedGoogle Scholar
  9. 9.
    Watson AF, Mellanby E. Tar cancer in mice. The condition of the skin when modified by external treatment or diet. Brit J Exp Path 1930, 11: 311–22Google Scholar
  10. 10.
    Weisburger JH, Reddy BS, Wynder EL. Colon cancer: its epidemiology and experimental production. Cancer 1977, 40: 2414–20PubMedCrossRefGoogle Scholar
  11. 11.
    Chan PC, Head JF, Cohen LA, Wynder EL. Influence of dietary fat on the induction of mammary tumours by N-nitrosomethy1 urea. J Nat Cancer Inst 1977, 59: 1279–83PubMedGoogle Scholar
  12. 12.
    Department of Statistics and Information. Japanese Ministry of Health and Welfare, 1982.Google Scholar
  13. 13.
    Kark JD, Smith AH, Harnes CG. Serum retinol and the inverse relationship between serum cholesterol and cancer. Brit Med J 1982, 284: 152–54CrossRefGoogle Scholar
  14. 14.
    Wald NJ. Vitamin A and cancer in humans. In Disease and the Environment. Eds Rees, Purcell. New York: WileyGoogle Scholar
  15. 15.
    Oliver MF. Diet and coronary heart disease. Brit Med Buil 1981, 37: 49–58Google Scholar
  16. 16.
    Lewis B, Hansen JDL, Wittman W, Krut LH. Plasma free fatty acids in kwashiorkor and the pathogenesis of the fatty liver. Am J Clin Nutrit 1964, 15: 161–68PubMedGoogle Scholar
  17. 17.
    Committee of Principal Investigators Report on a WHO Cooperative Trial on Primary Prevention of Ischaemic Heart Disease using Clofibrate to lower Serum Cholesterol - Mortality Follow-uo. Lancet 1980, ii: 379–384Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • B. Lewis
  • M. Mancini

There are no affiliations available

Personalised recommendations